Rory Landon Cochran, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Teratoma | 1 | 2024 | 403 | 0.760 |
Why?
|
Heart Neoplasms | 1 | 2024 | 360 | 0.740 |
Why?
|
Personnel Selection | 1 | 2021 | 194 | 0.650 |
Why?
|
Magnetic Resonance Angiography | 1 | 2023 | 1431 | 0.540 |
Why?
|
DNA, Neoplasm | 5 | 2017 | 1745 | 0.440 |
Why?
|
Loss of Heterozygosity | 2 | 2014 | 659 | 0.420 |
Why?
|
Research | 1 | 2021 | 1976 | 0.410 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2017 | 1096 | 0.360 |
Why?
|
BRCA2 Protein | 1 | 2014 | 798 | 0.320 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1147 | 0.320 |
Why?
|
Breast Neoplasms | 11 | 2017 | 21017 | 0.310 |
Why?
|
Polymerase Chain Reaction | 5 | 2017 | 6068 | 0.300 |
Why?
|
Balloon Occlusion | 2 | 2019 | 125 | 0.300 |
Why?
|
Students, Medical | 1 | 2021 | 1927 | 0.300 |
Why?
|
Radiology | 1 | 2021 | 2102 | 0.280 |
Why?
|
Fever | 2 | 2024 | 1617 | 0.270 |
Why?
|
Models, Genetic | 1 | 2015 | 3441 | 0.250 |
Why?
|
Placenta Accreta | 2 | 2019 | 237 | 0.240 |
Why?
|
Centrosome | 2 | 2015 | 207 | 0.230 |
Why?
|
Sweet Syndrome | 1 | 2024 | 58 | 0.230 |
Why?
|
Splenomegaly | 1 | 2024 | 189 | 0.220 |
Why?
|
Common Variable Immunodeficiency | 1 | 2024 | 102 | 0.220 |
Why?
|
Skin Ulcer | 1 | 2024 | 129 | 0.210 |
Why?
|
Polyps | 1 | 2024 | 197 | 0.200 |
Why?
|
Phlebography | 1 | 2023 | 325 | 0.200 |
Why?
|
Mutation | 10 | 2017 | 29915 | 0.200 |
Why?
|
Genomic Instability | 3 | 2017 | 704 | 0.190 |
Why?
|
Puerperal Disorders | 1 | 2024 | 299 | 0.190 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2024 | 244 | 0.190 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2017 | 895 | 0.190 |
Why?
|
Internship and Residency | 1 | 2021 | 5865 | 0.180 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36284 | 0.170 |
Why?
|
Lymphoma, Follicular | 1 | 2024 | 453 | 0.170 |
Why?
|
Occipital Lobe | 1 | 2021 | 373 | 0.170 |
Why?
|
Exanthema | 1 | 2024 | 504 | 0.160 |
Why?
|
Incidental Findings | 1 | 2024 | 694 | 0.160 |
Why?
|
Cell Cycle | 3 | 2017 | 2930 | 0.160 |
Why?
|
Syndrome | 1 | 2024 | 3262 | 0.150 |
Why?
|
World Health Organization | 1 | 2024 | 1312 | 0.150 |
Why?
|
Abdominal Pain | 1 | 2024 | 1063 | 0.150 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2015 | 2858 | 0.150 |
Why?
|
Extremities | 1 | 2023 | 865 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2024 | 650 | 0.140 |
Why?
|
Breast | 3 | 2017 | 1963 | 0.140 |
Why?
|
Radiology Department, Hospital | 1 | 2021 | 405 | 0.140 |
Why?
|
Radiology, Interventional | 1 | 2021 | 475 | 0.140 |
Why?
|
Iliac Artery | 1 | 2017 | 342 | 0.130 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2021 | 1066 | 0.130 |
Why?
|
Dogs | 1 | 2021 | 3840 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 265 | 0.130 |
Why?
|
Thymosin | 1 | 2015 | 47 | 0.130 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2912 | 0.130 |
Why?
|
Liver Diseases | 1 | 2024 | 1296 | 0.130 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4313 | 0.120 |
Why?
|
Heredity | 1 | 2015 | 148 | 0.120 |
Why?
|
Cell Proliferation | 8 | 2022 | 10416 | 0.120 |
Why?
|
Chromosomes, Human, Y | 1 | 2015 | 161 | 0.120 |
Why?
|
Phlebotomy | 1 | 2015 | 137 | 0.120 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1763 | 0.120 |
Why?
|
Cell Line, Transformed | 1 | 2015 | 869 | 0.120 |
Why?
|
Hydrolases | 1 | 2014 | 146 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2016 | 8506 | 0.110 |
Why?
|
Heterozygote | 3 | 2015 | 2797 | 0.110 |
Why?
|
Breast Neoplasms, Male | 1 | 2015 | 221 | 0.110 |
Why?
|
Receptor, erbB-3 | 1 | 2014 | 143 | 0.110 |
Why?
|
Tomography, X-Ray Computed | 4 | 2024 | 20500 | 0.110 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 631 | 0.110 |
Why?
|
Infection Control | 1 | 2021 | 982 | 0.110 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 653 | 0.110 |
Why?
|
Radiation Tolerance | 1 | 2015 | 480 | 0.110 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 344 | 0.100 |
Why?
|
Phenotype | 5 | 2017 | 16534 | 0.100 |
Why?
|
Ischemia | 1 | 2021 | 1863 | 0.100 |
Why?
|
Cell Hypoxia | 1 | 2014 | 655 | 0.100 |
Why?
|
Gene Knockout Techniques | 2 | 2017 | 802 | 0.100 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7403 | 0.100 |
Why?
|
Estrogen Receptor alpha | 1 | 2015 | 580 | 0.090 |
Why?
|
Gene Deletion | 2 | 2015 | 2666 | 0.090 |
Why?
|
Humans | 36 | 2024 | 758406 | 0.090 |
Why?
|
Transfection | 2 | 2015 | 5779 | 0.090 |
Why?
|
Ultrasonography | 1 | 2024 | 5952 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2017 | 1077 | 0.090 |
Why?
|
Skin | 1 | 2024 | 4464 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 726 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2013 | 3664 | 0.090 |
Why?
|
Tamoxifen | 1 | 2014 | 963 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2014 | 1245 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2021 | 1246 | 0.080 |
Why?
|
Haploinsufficiency | 1 | 2011 | 327 | 0.080 |
Why?
|
Liver Transplantation | 1 | 2021 | 2325 | 0.080 |
Why?
|
Mutation, Missense | 2 | 2015 | 2564 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2292 | 0.080 |
Why?
|
Female | 23 | 2024 | 390323 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7502 | 0.080 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2014 | 615 | 0.080 |
Why?
|
Catheter Ablation | 1 | 2021 | 2740 | 0.070 |
Why?
|
Estrogens | 1 | 2014 | 1520 | 0.070 |
Why?
|
ras Proteins | 1 | 2013 | 1049 | 0.070 |
Why?
|
Genes, BRCA1 | 1 | 2011 | 765 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2021 | 2139 | 0.070 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2015 | 2825 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 951 | 0.070 |
Why?
|
Insulin | 1 | 2021 | 6578 | 0.070 |
Why?
|
Signal Transduction | 4 | 2022 | 23342 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2022 | 16886 | 0.070 |
Why?
|
Tumor Suppressor Proteins | 1 | 2015 | 2800 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2872 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2553 | 0.060 |
Why?
|
Suppuration | 1 | 2024 | 61 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2024 | 12951 | 0.060 |
Why?
|
Relapsing Fever | 1 | 2024 | 24 | 0.060 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2024 | 40 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2024 | 33 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3609 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2015 | 2504 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3442 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2523 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2024 | 174 | 0.060 |
Why?
|
Cell Movement | 1 | 2015 | 5201 | 0.050 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5249 | 0.050 |
Why?
|
Genotype | 2 | 2017 | 12945 | 0.050 |
Why?
|
Gallbladder Diseases | 1 | 2024 | 137 | 0.050 |
Why?
|
Perineum | 1 | 2024 | 208 | 0.050 |
Why?
|
Alleles | 1 | 2014 | 6895 | 0.050 |
Why?
|
Digestive System Diseases | 1 | 2024 | 151 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2010 | 1262 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5816 | 0.050 |
Why?
|
Doxycycline | 1 | 2024 | 341 | 0.050 |
Why?
|
RNA Interference | 3 | 2015 | 2836 | 0.050 |
Why?
|
Granuloma | 1 | 2024 | 327 | 0.050 |
Why?
|
Multiple Pulmonary Nodules | 1 | 2024 | 167 | 0.050 |
Why?
|
Anal Canal | 1 | 2024 | 372 | 0.050 |
Why?
|
Proteomics | 1 | 2014 | 3816 | 0.050 |
Why?
|
Gene Amplification | 2 | 2017 | 1085 | 0.050 |
Why?
|
Time Factors | 3 | 2021 | 39872 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2013 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2013 | 4485 | 0.050 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2021 | 347 | 0.040 |
Why?
|
Microwaves | 1 | 2021 | 185 | 0.040 |
Why?
|
Middle Aged | 10 | 2024 | 219568 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2022 | 495 | 0.040 |
Why?
|
Biopsy | 2 | 2024 | 6768 | 0.040 |
Why?
|
Aged | 9 | 2024 | 168218 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2021 | 15637 | 0.040 |
Why?
|
Drainage | 1 | 2024 | 1161 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2017 | 2012 | 0.040 |
Why?
|
Standard of Care | 1 | 2022 | 550 | 0.040 |
Why?
|
Abdomen | 1 | 2024 | 1129 | 0.040 |
Why?
|
Gravidity | 1 | 2017 | 50 | 0.040 |
Why?
|
Observer Variation | 1 | 2024 | 2600 | 0.040 |
Why?
|
Neoplasms | 3 | 2015 | 22032 | 0.040 |
Why?
|
Postpartum Period | 1 | 2024 | 1167 | 0.040 |
Why?
|
Mice, Nude | 2 | 2014 | 3602 | 0.040 |
Why?
|
Cell Line | 3 | 2015 | 15591 | 0.040 |
Why?
|
Animals | 5 | 2021 | 167768 | 0.030 |
Why?
|
Metaplasia | 1 | 2017 | 321 | 0.030 |
Why?
|
DNA Mutational Analysis | 2 | 2015 | 4106 | 0.030 |
Why?
|
Centromere | 1 | 2017 | 213 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2024 | 1401 | 0.030 |
Why?
|
Microchemistry | 1 | 2015 | 54 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2015 | 4257 | 0.030 |
Why?
|
Colony-Forming Units Assay | 1 | 2015 | 351 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2024 | 80168 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2016 | 4901 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2144 | 0.030 |
Why?
|
Cell Shape | 1 | 2015 | 371 | 0.030 |
Why?
|
Genes, Mitochondrial | 1 | 2014 | 61 | 0.030 |
Why?
|
Mammary Glands, Human | 1 | 2015 | 203 | 0.030 |
Why?
|
Parity | 1 | 2017 | 925 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3615 | 0.030 |
Why?
|
Consensus | 1 | 2024 | 3099 | 0.030 |
Why?
|
Adult | 8 | 2024 | 219935 | 0.030 |
Why?
|
Bone Marrow | 1 | 2024 | 2909 | 0.030 |
Why?
|
Risk Assessment | 1 | 2015 | 23884 | 0.030 |
Why?
|
Cell Respiration | 1 | 2014 | 202 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17768 | 0.030 |
Why?
|
Blood Chemical Analysis | 1 | 2015 | 437 | 0.030 |
Why?
|
Clone Cells | 1 | 2017 | 1660 | 0.030 |
Why?
|
Base Sequence | 2 | 2014 | 12436 | 0.030 |
Why?
|
Hemolysis | 1 | 2015 | 423 | 0.030 |
Why?
|
Drug Therapy | 1 | 2016 | 503 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 55 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 100 | 0.030 |
Why?
|
Lower Extremity | 1 | 2021 | 1188 | 0.030 |
Why?
|
Risk Factors | 2 | 2021 | 73809 | 0.030 |
Why?
|
Phosphorylation | 2 | 2014 | 8297 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
Cancer Care Facilities | 1 | 2015 | 424 | 0.030 |
Why?
|
Immunoblotting | 1 | 2015 | 1647 | 0.030 |
Why?
|
Gene Targeting | 1 | 2015 | 837 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2021 | 64378 | 0.030 |
Why?
|
Preoperative Care | 1 | 2021 | 2249 | 0.020 |
Why?
|
Plasma | 1 | 2015 | 584 | 0.020 |
Why?
|
Recurrence | 1 | 2024 | 8426 | 0.020 |
Why?
|
Hysterectomy | 1 | 2017 | 904 | 0.020 |
Why?
|
Aneuploidy | 1 | 2015 | 551 | 0.020 |
Why?
|
Tubulin | 1 | 2015 | 692 | 0.020 |
Why?
|
Societies, Medical | 1 | 2024 | 3891 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2013 | 419 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2014 | 835 | 0.020 |
Why?
|
Preoperative Period | 1 | 2014 | 553 | 0.020 |
Why?
|
Hemangioendothelioma | 1 | 1972 | 111 | 0.020 |
Why?
|
Transgenes | 1 | 2014 | 1007 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2017 | 1321 | 0.020 |
Why?
|
Homozygote | 1 | 2015 | 1788 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 611 | 0.020 |
Why?
|
Placenta | 1 | 2019 | 1702 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2014 | 1527 | 0.020 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1112 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1218 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14641 | 0.020 |
Why?
|
Quinolines | 1 | 2015 | 759 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2010 | 122 | 0.020 |
Why?
|
Pelvic Neoplasms | 1 | 1972 | 248 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2021 | 2055 | 0.020 |
Why?
|
Male | 7 | 2024 | 358747 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1728 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2021 | 58683 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1360 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5065 | 0.020 |
Why?
|
Postoperative Period | 1 | 2014 | 1812 | 0.020 |
Why?
|
Cesarean Section | 1 | 2017 | 1385 | 0.020 |
Why?
|
Odds Ratio | 1 | 2021 | 9650 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1220 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3612 | 0.020 |
Why?
|
Actins | 1 | 2015 | 2049 | 0.020 |
Why?
|
Thiazoles | 1 | 2015 | 1510 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1489 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5031 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2014 | 1845 | 0.020 |
Why?
|
Mice | 4 | 2017 | 81101 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2387 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1346 | 0.020 |
Why?
|
Zinc Fingers | 1 | 2010 | 568 | 0.020 |
Why?
|
Point Mutation | 1 | 2013 | 1593 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3796 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 2013 | 856 | 0.020 |
Why?
|
Genome | 1 | 2015 | 1739 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20055 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13468 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1492 | 0.020 |
Why?
|
Pregnancy | 2 | 2019 | 29742 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7378 | 0.020 |
Why?
|
Infant, Newborn, Diseases | 1 | 1972 | 592 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2210 | 0.020 |
Why?
|
Pedigree | 1 | 2014 | 4578 | 0.020 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3432 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5349 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2013 | 1477 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6187 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2014 | 3432 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 1725 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 1507 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2015 | 5864 | 0.020 |
Why?
|
Homeostasis | 1 | 2015 | 3301 | 0.010 |
Why?
|
Genetic Testing | 1 | 2017 | 3530 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8175 | 0.010 |
Why?
|
United States | 2 | 2021 | 72136 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 17617 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7583 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 3754 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8611 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14354 | 0.010 |
Why?
|
Prospective Studies | 2 | 2015 | 54137 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39059 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11152 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 41256 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9460 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18119 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5786 | 0.010 |
Why?
|
Prognosis | 1 | 2014 | 29557 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 87892 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2010 | 9574 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15773 | 0.010 |
Why?
|
Buttocks | 1 | 1972 | 111 | 0.010 |
Why?
|
Transcription Factors | 1 | 2010 | 12094 | 0.010 |
Why?
|
Arteriovenous Malformations | 1 | 1972 | 397 | 0.010 |
Why?
|
Heart Failure | 1 | 1972 | 11593 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1972 | 26183 | 0.000 |
Why?
|